PDB Short entry for 3HHU HEADER CHAPERONE 17-MAY-09 3HHU TITLE HUMAN HEAT-SHOCK PROTEIN 90 (HSP90) IN COMPLEX WITH {4-[3-(2,4- TITLE 2 DIHYDROXY-5-ISOPROPYL-PHENYL)-5-THIOXO- 1,5-DIHYDRO-[1,2,4]TRIAZOL-4- TITLE 3 YL]-BENZYL}-CARBAMIC ACID ETHYL ESTER {ZK 2819} COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAT SHOCK PROTEIN HSP 90-ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 1-224; COMPND 5 SYNONYM: HSP 86, RENAL CARCINOMA ANTIGEN NY-REN-38 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 OTHER_DETAILS: PURIFIED N-TERMINAL DOMAIN OF HSP90, CRELUX GMBH SOURCE 6 (MARTINSRIED GERMANY) KEYWDS HSP90, ATPASE, CHAPERONE, ATP-BINDING, HEAT SHOCK, NUCLEOTIDE- KEYWDS 2 BINDING, PHOSPHORYLATION, ALTERNATIVE SPLICING, CYTOPLASM, KEYWDS 3 PHOSPHOPROTEIN, STRESS RESPONSE EXPDTA X-RAY DIFFRACTION AUTHOR M.ADLER,M.WHITLOW REVDAT 2 01-NOV-17 3HHU 1 REMARK REVDAT 1 14-JUL-09 3HHU 0 JRNL AUTH R.I.FELDMAN,B.MINTZER,D.ZHU,J.M.WU,S.L.BIROC,S.YUAN, JRNL AUTH 2 K.EMAYAN,Z.CHANG,D.CHEN,D.O.ARNAIZ,J.BRYANT,X.S.GE, JRNL AUTH 3 M.WHITLOW,M.ADLER,M.A.POLOKOFF,W.W.LI,M.FERRER,T.SATO, JRNL AUTH 4 J.M.GU,J.SHEN,J.L.TSENG,H.DINTER,B.BUCKMAN JRNL TITL POTENT TRIAZOLOTHIONE INHIBITOR OF HEAT-SHOCK PROTEIN-90. JRNL REF CHEM.BIOL.DRUG DES. V. 74 43 2009 JRNL REFN ISSN 1747-0277 JRNL PMID 19519743 JRNL DOI 10.1111/J.1747-0285.2009.00833.X REMARK 2 REMARK 2 RESOLUTION. 1.59 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.59 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 140750.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 81.8 REMARK 3 NUMBER OF REFLECTIONS : 65188 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2614 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2380 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2370 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3148 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0050 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 79085 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.59 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.69 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 62.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7848 REMARK 3 BIN R VALUE (WORKING SET) : 0.2550 REMARK 3 BIN FREE R VALUE : 0.2820 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 332 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3280 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 564 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.51000 REMARK 3 B22 (A**2) : 6.76000 REMARK 3 B33 (A**2) : -3.25000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.16 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 0.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.660 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.410 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.980 ; 2.500 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.600 ; 2.500 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.710 ; 3.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 50.05 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : 819.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : 819.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ATOMS C1 TO C8 IN INHIBITOR ZK 7002819 REMARK 3 IN THE FIRST HSP90 MOLECULE, RESIDUES 500, HAVE BEEN REPLACED BY REMARK 3 THOSE FROM A PREVIOUS XPLOR REFINEMENT COOL_09C1.PDB. REMARK 4 REMARK 4 3HHU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-MAY-09. REMARK 100 THE DEPOSITION ID IS D_1000053151. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 101.400002 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, X-GEN REMARK 200 DATA SCALING SOFTWARE : SCALA, X-GEN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 79136 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.590 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 3.490 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09530 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.7900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.59 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.58 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.39320 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.690 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: MOLREP, CCP4 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.91 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M MGCL, 30% PEG4000,0.1M TRIS, PH REMARK 280 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 278K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 32.50950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.01800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.50950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.01800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 GLU A 3 REMARK 465 GLU A 4 REMARK 465 THR A 5 REMARK 465 GLN A 6 REMARK 465 THR A 7 REMARK 465 GLN A 8 REMARK 465 ASP A 9 REMARK 465 GLN A 10 REMARK 465 PRO A 11 REMARK 465 MET A 12 REMARK 465 GLU A 13 REMARK 465 GLU A 14 REMARK 465 GLU A 15 REMARK 465 LYS A 224 REMARK 465 MET B 1 REMARK 465 PRO B 2 REMARK 465 GLU B 3 REMARK 465 GLU B 4 REMARK 465 THR B 5 REMARK 465 GLN B 6 REMARK 465 THR B 7 REMARK 465 GLN B 8 REMARK 465 ASP B 9 REMARK 465 GLN B 10 REMARK 465 PRO B 11 REMARK 465 MET B 12 REMARK 465 GLU B 13 REMARK 465 GLU B 14 REMARK 465 GLU B 15 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 38 109.26 -161.11 REMARK 500 THR A 94 41.25 -108.64 REMARK 500 ALA A 166 -145.16 68.47 REMARK 500 ARG A 182 140.09 -172.06 REMARK 500 TYR B 38 109.96 -164.80 REMARK 500 ALA B 111 -122.82 51.03 REMARK 500 ALA B 166 -145.87 63.22 REMARK 500 ARG B 182 138.53 -173.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 819 A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 819 B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BYQ RELATED DB: PDB REMARK 900 HSP90 N-TERMINAL DOMAIN BOUND TO ADP-MG REMARK 900 RELATED ID: 1OSF RELATED DB: PDB REMARK 900 HUMAN HSP90 IN COMPLEX WITH 17-DESMETHOXY-17-N,N- REMARK 900 DIMETHYLAMINOETHYLAMINO-GELDANAMYCIN REMARK 900 RELATED ID: 1UY6 RELATED DB: PDB REMARK 900 RELATED ID: 1YC1 RELATED DB: PDB REMARK 900 RELATED ID: 1YET RELATED DB: PDB REMARK 900 RELATED ID: 2BSM RELATED DB: PDB REMARK 900 RELATED ID: 2BTO RELATED DB: PDB REMARK 900 RELATED ID: 2BYI RELATED DB: PDB REMARK 900 RELATED ID: 2C2L RELATED DB: PDB REMARK 900 RELATED ID: 2CCT RELATED DB: PDB REMARK 900 RELATED ID: 2CCU RELATED DB: PDB DBREF 3HHU A 1 224 UNP P07900 HS90A_HUMAN 1 224 DBREF 3HHU B 1 224 UNP P07900 HS90A_HUMAN 1 224 SEQRES 1 A 224 MET PRO GLU GLU THR GLN THR GLN ASP GLN PRO MET GLU SEQRES 2 A 224 GLU GLU GLU VAL GLU THR PHE ALA PHE GLN ALA GLU ILE SEQRES 3 A 224 ALA GLN LEU MET SER LEU ILE ILE ASN THR PHE TYR SER SEQRES 4 A 224 ASN LYS GLU ILE PHE LEU ARG GLU LEU ILE SER ASN SER SEQRES 5 A 224 SER ASP ALA LEU ASP LYS ILE ARG TYR GLU SER LEU THR SEQRES 6 A 224 ASP PRO SER LYS LEU ASP SER GLY LYS GLU LEU HIS ILE SEQRES 7 A 224 ASN LEU ILE PRO ASN LYS GLN ASP ARG THR LEU THR ILE SEQRES 8 A 224 VAL ASP THR GLY ILE GLY MET THR LYS ALA ASP LEU ILE SEQRES 9 A 224 ASN ASN LEU GLY THR ILE ALA LYS SER GLY THR LYS ALA SEQRES 10 A 224 PHE MET GLU ALA LEU GLN ALA GLY ALA ASP ILE SER MET SEQRES 11 A 224 ILE GLY GLN PHE GLY VAL GLY PHE TYR SER ALA TYR LEU SEQRES 12 A 224 VAL ALA GLU LYS VAL THR VAL ILE THR LYS HIS ASN ASP SEQRES 13 A 224 ASP GLU GLN TYR ALA TRP GLU SER SER ALA GLY GLY SER SEQRES 14 A 224 PHE THR VAL ARG THR ASP THR GLY GLU PRO MET GLY ARG SEQRES 15 A 224 GLY THR LYS VAL ILE LEU HIS LEU LYS GLU ASP GLN THR SEQRES 16 A 224 GLU TYR LEU GLU GLU ARG ARG ILE LYS GLU ILE VAL LYS SEQRES 17 A 224 LYS HIS SER GLN PHE ILE GLY TYR PRO ILE THR LEU PHE SEQRES 18 A 224 VAL GLU LYS SEQRES 1 B 224 MET PRO GLU GLU THR GLN THR GLN ASP GLN PRO MET GLU SEQRES 2 B 224 GLU GLU GLU VAL GLU THR PHE ALA PHE GLN ALA GLU ILE SEQRES 3 B 224 ALA GLN LEU MET SER LEU ILE ILE ASN THR PHE TYR SER SEQRES 4 B 224 ASN LYS GLU ILE PHE LEU ARG GLU LEU ILE SER ASN SER SEQRES 5 B 224 SER ASP ALA LEU ASP LYS ILE ARG TYR GLU SER LEU THR SEQRES 6 B 224 ASP PRO SER LYS LEU ASP SER GLY LYS GLU LEU HIS ILE SEQRES 7 B 224 ASN LEU ILE PRO ASN LYS GLN ASP ARG THR LEU THR ILE SEQRES 8 B 224 VAL ASP THR GLY ILE GLY MET THR LYS ALA ASP LEU ILE SEQRES 9 B 224 ASN ASN LEU GLY THR ILE ALA LYS SER GLY THR LYS ALA SEQRES 10 B 224 PHE MET GLU ALA LEU GLN ALA GLY ALA ASP ILE SER MET SEQRES 11 B 224 ILE GLY GLN PHE GLY VAL GLY PHE TYR SER ALA TYR LEU SEQRES 12 B 224 VAL ALA GLU LYS VAL THR VAL ILE THR LYS HIS ASN ASP SEQRES 13 B 224 ASP GLU GLN TYR ALA TRP GLU SER SER ALA GLY GLY SER SEQRES 14 B 224 PHE THR VAL ARG THR ASP THR GLY GLU PRO MET GLY ARG SEQRES 15 B 224 GLY THR LYS VAL ILE LEU HIS LEU LYS GLU ASP GLN THR SEQRES 16 B 224 GLU TYR LEU GLU GLU ARG ARG ILE LYS GLU ILE VAL LYS SEQRES 17 B 224 LYS HIS SER GLN PHE ILE GLY TYR PRO ILE THR LEU PHE SEQRES 18 B 224 VAL GLU LYS HET 819 A 500 30 HET 819 B 501 30 HETNAM 819 ETHYL (4-{3-[2,4-DIHYDROXY-5-(1-METHYLETHYL)PHENYL]-5- HETNAM 2 819 SULFANYL-4H-1,2,4-TRIAZOL-4-YL}BENZYL)CARBAMATE FORMUL 3 819 2(C21 H24 N4 O4 S) FORMUL 5 HOH *564(H2 O) HELIX 1 1 GLN A 23 THR A 36 1 14 HELIX 2 2 ASN A 40 GLU A 42 5 3 HELIX 3 3 ILE A 43 LEU A 64 1 22 HELIX 4 4 THR A 65 ASP A 71 5 7 HELIX 5 5 THR A 99 ASN A 105 1 7 HELIX 6 6 ASN A 106 THR A 109 5 4 HELIX 7 7 ILE A 110 ALA A 124 1 15 HELIX 8 8 ASP A 127 GLY A 135 5 9 HELIX 9 9 VAL A 136 LEU A 143 5 8 HELIX 10 10 GLN A 194 LEU A 198 5 5 HELIX 11 11 GLU A 199 SER A 211 1 13 HELIX 12 12 GLN B 23 THR B 36 1 14 HELIX 13 13 ASN B 40 GLU B 42 5 3 HELIX 14 14 ILE B 43 ASP B 66 1 24 HELIX 15 15 PRO B 67 ASP B 71 5 5 HELIX 16 16 THR B 99 THR B 109 1 11 HELIX 17 17 GLY B 114 GLN B 123 1 10 HELIX 18 18 ASP B 127 GLY B 135 5 9 HELIX 19 19 VAL B 136 LEU B 143 5 8 HELIX 20 20 GLN B 194 LEU B 198 5 5 HELIX 21 21 GLU B 199 SER B 211 1 13 SHEET 1 A 8 GLU A 18 ALA A 21 0 SHEET 2 A 8 SER A 169 THR A 174 -1 O PHE A 170 N PHE A 20 SHEET 3 A 8 TYR A 160 SER A 164 -1 N ALA A 161 O ARG A 173 SHEET 4 A 8 ALA A 145 LYS A 153 -1 N VAL A 150 O TRP A 162 SHEET 5 A 8 GLY A 183 LEU A 190 -1 O LYS A 185 N ILE A 151 SHEET 6 A 8 THR A 88 ASP A 93 -1 N ILE A 91 O VAL A 186 SHEET 7 A 8 ILE A 78 ASN A 83 -1 N ASN A 79 O VAL A 92 SHEET 8 A 8 ILE A 218 LEU A 220 1 O THR A 219 N LEU A 80 SHEET 1 B 8 VAL B 17 ALA B 21 0 SHEET 2 B 8 SER B 169 THR B 174 -1 O PHE B 170 N PHE B 20 SHEET 3 B 8 TYR B 160 SER B 164 -1 N ALA B 161 O ARG B 173 SHEET 4 B 8 ALA B 145 LYS B 153 -1 N VAL B 150 O TRP B 162 SHEET 5 B 8 GLY B 183 LEU B 190 -1 O LYS B 185 N ILE B 151 SHEET 6 B 8 THR B 88 ASP B 93 -1 N LEU B 89 O LEU B 188 SHEET 7 B 8 ILE B 78 ASN B 83 -1 N ASN B 79 O VAL B 92 SHEET 8 B 8 ILE B 218 LEU B 220 1 O THR B 219 N LEU B 80 SITE 1 AC1 16 ASN A 51 ALA A 55 ASP A 93 GLY A 97 SITE 2 AC1 16 MET A 98 LEU A 107 GLY A 108 THR A 109 SITE 3 AC1 16 ILE A 110 GLY A 135 PHE A 138 THR A 184 SITE 4 AC1 16 VAL A 186 HOH A 645 HOH A 828 HOH A 982 SITE 1 AC2 15 ASN B 51 ALA B 55 ASP B 93 GLY B 97 SITE 2 AC2 15 MET B 98 ASN B 106 LEU B 107 GLY B 135 SITE 3 AC2 15 VAL B 136 GLY B 137 PHE B 138 THR B 184 SITE 4 AC2 15 VAL B 186 HOH B 695 HOH B 718 CRYST1 65.019 90.036 100.040 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015380 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011107 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009996 0.00000